Nutraceuticals and nootropics for anti-aging

1-Androstenedione outperforms previous anabolic supplement

The following quote is taken from U.S. patent # 6,391,868 and compares the benefits of two generations of anabolic supplements — in this case, 4-Androstenedione vs. the new anabolic, 1-Androstenedione:

“A 64-year-old man with complaints of decreased libido, lethargy, depression, and muscular weakness, was treated for 4 weeks with oral androstenedione [4-Androstenedione] 3×100 mg daily. At the end of the 4 weeks he did not report any noticeable improvement in his condition. After a 2-week respite, he then commenced a 4-week regimen of 5alpha-androst-1-en-3,17-dione [1-Androstenedione] using the same protocol (3×100 mg daily). After the 4 weeks was completed he reported clearly evident significant improvements in all his symptoms which included marked increases in his exercise capacity.”

Link to the patent:

Patent # 6391868